Abstract
Previous data have demonstrated that CXC-chemokine platelet factor 4 (PF4) inhibits the proliferation of the human erythroleukemia cell line (HEL). However, the mechanism of action is unclear at present. The signaling transduction induced by PF4 in the HEL was compared with that induced by transforming growth factor β1 (TGF-β4), which is also a potent inhibitor of HEL growth. It was found that PF4 had no inhibitory effect on intracellular calcium levels in resting HEL cells. When HEL cells were stimulated with interleukin-3 (IL-3), a rapid increase in the intracellular level of free calcium occurred within 15 to 20 seconds, and this increase was followed by a sustained increase that gradually declined until resting levels were reached 30 to 40 minutes later. PF4 dramatically decreased the transient rise of [Ca2+] and protein kinase C (PKC) activity of HEL cells induced by IL-3. However, PF4 had no inhibitory effect on PKC activation in resting HEL cells. Furthermore, PF4 was found to down-regulate significantly protein tyrosine kinase (PTK) activity. In contrast, TGF-β1 induced an increase in intracellular free calcium concentration and PKC and PTK activity in HEL cells. Furthermore, PF4 significantly increased the messenger RNA (mRNA) level of p21waf1 in HEL cells. These data demonstrate that PF4 acts on HEL cells through a signaling transduction pathway, which is different from that of TGF-β1 and is related to the up-regulatory mRNA level of p21waf1 in HEL cells.
Similar content being viewed by others
References
Rollins BJ. Chemokines.Blood. 1997;90:909–928.
Han ZC, Sensebe L, Abgrall JF, Briere J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro.Blood. 1990;75:1234–1239.
Broxmeyer HE, Sherry B, Cooper S, et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human progenitor cells: interacting effects involving suppression, synergistic suppression, and blocking of suppression.J Immunol. 1993;150:3448–3458.
Gewirtz AM, Calabretta B, Rucinski B, et al. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.J Clin Invest. 1989; 83: 1477–1482.
Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.Cell. 1994;79:487–496.
Pagano M, Tam SW, Theodras AM, et al. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclindependent kinase inhibitor p27.Science. 1995;269:682–685.
Kao JPY, Harootunian AT, Tsien RY. Photochemically generated cytosolic calcium pulses and their detection by fluo-3.J Biol Chem. 1989;264:8179–8184.
Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C.Biochem Biophys Res Commun. 1990;166: 1220–1227.
Pike LJ, Gallis B, Casnellie JE, Bornstein P, Krebs EG. Epidermal growth factor stimulates the phosphorylation of synthetic tyrosinecontaining peptides by A431 cell membranes.Proc Natl Acad Sci US A. 1982;79:1443–1447.
Umezawa K, Hori T, Tajima H, Imoto M, Isshiki K, Takeuchi T. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.FEBS Lett. 1990;260:198–200.
Sambrook J, Fritsch EF, Maniatis T.Molecular Cloning: A Laboratory Manual. Vol. 1-3. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
Newton AC. Protein kinase C: structure, function, and regulation.J Biol Chem. 1995;270:28495–28498.
Foreback JL, Sarma V, Yeager NR, Younkin EM, Remick DG, Ward PA. Blood mononuclear cell production of TNF-α and IL-8: engagement of different signal transduction pathways including the p42 MAP kinase pathway.J Leukoc Biol. 1998;64:124–133.
Maxfield FR. Ca2+ regulation of neutrophil chemotaxis.Trends Cell Biol. 1993;3:386–391.
Thelen M, Dewald B, Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst.Physiol Rev. 1993;73: 797–822.
Isfort RJ, Ihle JN. Multiple hematopoietic growth factors signal through tyrosine phosphorylation.Growth Factors. 1990;2:213–220.
Ullich A, Schlessingeer J. Signal transduction by receptors with tyrosine kinase activity.Cell. 1990;61:203–212.
Han ZC, Bellucci S, Wan HY, Caen JP. New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblast growth factors and transforming growth factor β.Br J Haematol. 1992;81:1–5.
Han ZC, Maurer AM, Bellucci S, et al. Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.J Lab Clin Med. 1992;120: 645–660.
Xi XD, Caen JP, Fournier S, et al. Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor β1.Br J Haematol. 1996;93:490.
Hu X, Zuckerman KS. Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis.J Hematother Stem Cell Res. 2001;10:67–74.
Mui ALF, Wakao H, Harada N, O’Farrell AM, Migajjma A. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms and STAT5.J Leukoc Biol. 1995;57:799–803.
Whelham MJ, Duronio V, Sanghera JS, Pelech SL, Schrader JW. Multiple hematopoietic growth factors stimulate activation of mitogen-activated protein kinase family member.J Immunol. 1992; 149:1683–1693.
Gupta SK, Singh JP. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.J Cell Biol. 1994;127:1121–2711.
Gentilini G, Kirschbaum NE, Augustine JA, Aster RH, Visendtin GP. Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21cip1/WAF1.Blood. 1999;939: 25–33.
Resnitzky D, Hengst L, Reed SI. Cyclin A—associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.Mol Cell Biol. 1995;15:4347–4352.
Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression.Genes Dev. 1999;13:1501–1512.
Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structure of Cdks, their cyclin activators, and Cip and INK4 inhibitors.J Mol Biol. 1999;287:821–828.
Dyson N. The regulation of E2F by pRB-family proteins.Genes Dev. 1998;12:2245–2262.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Liu, Y.J., Lu, S.H. & Han, Z.C. Signal Transduction of Chemokine Platelet Factor 4 in Human Erythroleukemia Cells. Int J Hematol 75, 401–406 (2002). https://doi.org/10.1007/BF02982132
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982132